Does fluorescent analogue of propranolol, 9-amino-acridine-propranolol, binding sites really show the beta-adrenoreceptors?
Murakami, E.; Shiosaka, S.; Tohyama, M.
Cellular and Molecular Biology Including Cyto-Enzymology 27(2-3): 133-137
1981
ISSN/ISBN: 0145-5680 PMID: 6271398 Document Number: 173227
Document emailed within 1 workday
Related Documents
Jaillon, P.; Hecklé, J.; Weissenburger, J.; Cheymol, G. 1980: Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs Journal of Pharmacology and Experimental Therapeutics 212(2): 347-353Rademaker, B.; Kramer, K.; Bast, A.; Timmerman, H. 1988: Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites Research Communications in Chemical Pathology and Pharmacology 60(2): 147-159
Albani, F.; Riva, R.; Baldrati, A.; Cortelli, P.; Perucca, E.; Procaccianti, G.; Baruzzi, A. 1984: Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose International Journal of Clinical Pharmacology Research 4(1): 19-23
Ongcharit, C.; Tungsanga, K. 1977: Propranolol and propranolol with thiazide in hypertensive Thai patients Journal of the Medical Association of Thailand 60(10): 465-469
Kusuzaki, K.; Murata, H.; Takeshita, H.; Hashiguchi, S.; Nozaki, T.; Emoto, K.; Ashihara, T.; Hirasawa, Y. 2000: Intracellular binding sites of acridine orange in living osteosarcoma cells Anticancer Research 20(2a): 971-975
Howell, R.E.; Lanken, P.N. 1992: Pulmonary accumulation of propranolol in vivo: sites and physiochemical mechanism Journal of Pharmacology and Experimental Therapeutics 263(1): 130-135
Verbeuren, T.J.; Zonnekeyn, L.L.; Prost, J.F.; Herman, A.G. 1989: Prejunctional beta-adrenoceptors in the isolated perfused rat kidney: a comparative study of the beta-blockers tertatolol and propranolol Archives Internationales de Pharmacodynamie et de Therapie 298: 183-197
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H. 1978: Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension Die Medizinische Welt 29(9): 366-367
Bai, S.A.; Abramson, F.P. 1982: Interactions of phenobarbital with propranolol in the dog. 1. Plasma protein binding Journal of Pharmacology and Experimental Therapeutics 222(3): 589-594
Davies, R.F.; Dubé, L.M.; Mousseau, N.; McGilveray, I.; Beanlands, D.S. 1988: Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations Journal of Thoracic and Cardiovascular Surgery 96(4): 634-641
Albani, F.; Riva, R.; Cortelli, P.; Contin, M.; Baruzzi, A. 1985: Propranolol plasma binding and serum lipids during chronic therapy in migraine patients International Journal of Clinical Pharmacology Therapy and Toxicology 23(5): 267-269
Vel'iaminov, I.B. 1970: Cytologic diagnosis of stomach cancer by the fluorescent method using acridine orange and ethyl-acridine orange fluorochrome Sovetskaia Meditsina 33(8): 82-86
Andrianova, I.V.; Rekhter, M.D.; Tertov, V.V.; Andreeva, E.R.; Mironov, A.A.; Orekhov, A.N. 1992: Elimination of the atherogenic effect of beta blocker propranolol by papaverine Biulleten' Eksperimental'noi Biologii i Meditsiny 113(3): 273-275
Ambrosioni, E.; Bracchetti, D.; Russo, F.; Catizone, L.; Perri, G.; Magnani, B. 1972: Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol Bollettino Della Societa Italiana di Cardiologia 17(2): 91-101
Felt, V. 1970: Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis Review of Czechoslovak Medicine 16(3): 140-144
Syvälahti, E.; Lammintausta, R.; Iisalo, E.; Kanto, J. 1977: Cardioselective (metoprolol) and non-selective (propranolol) beta-blockade and glucose homeostasis Annals of Clinical Research 9(5): 292-295
Tiula, E.; Haapanen, E.J.; Neuvonen, P.J. 1987: Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases International Journal of Clinical Pharmacology Therapy and Toxicology 25(9): 469-475
Pradalier, A.; Serratrice, G.; Collard, M.; Hirsch, E.; Feve, J.; Masson, M.; Masson, C.; Dry, J.; Koulikovsky, G.; Nguyen, G. 1990: Beta-blockers and migraine. Efficacy of time-release propranolol versus placebo Therapie 45(5): 441-445
Angelov, E.; Aleksieva, S. 1982: Inhibitory effect of beta blockader propranolol on demethylating activity of liver microsomes Eksperimentalna Meditsina i Morfologiia 21(1): 9-13
Bora, P.S.; Srivastava, L.M.; Bhatt, S.D. 1989: Myocardial dysfunction in diabetic rats: influence of beta-adrenoceptor blockade (propranolol) Indian Journal of Experimental Biology 27(7): 615-620